Malaria is caused by a parasite that is spread to humans by infected mosquitoes. In 2024, almost 282 million people worldwide were infected and 610,000 died, according to the World Health Organization ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Amgen (NASDAQ:AMGN) and its peers.

Commissioner Marty Makary on Friday announced that the agency’s top regulator Vinay Prasad will depart next month. “A year ...

CSL Seqirus was granted a contract to support flu pandemic preparedness plans for Canada's government. The flu vaccine manufacturer said Friday it would make and deliver millions of doses of ...

Patricia Treble is the royal specialist at Maclean’s. In addition to her interest in all things monarchical—from the Queen's ...

Novavax reported fourth-quarter earnings of 11 cents, a shift from a loss of 51 cents a year ago. evenue for the fourth quarter was $147 million, a 67% year-over-year increase. Novavax on Thursday ...

Novavax raised its adjusted revenue forecast for 2026 on Thursday, banking on milestone payments from licensing and supply deals for its shots, although it noted that the current regulatory ...

Vaccine biotechnology company Novavax (NASDAQ:NVAX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 66.6% year on year to $147.1 million. Its GAAP profit of $0.11 ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported fourth-quarter earnings of $17.5 million. On a per-share basis, the Gaithersburg, Maryland-based company said ...

Novavax beat analysts’ revenue expectations last quarter, reporting revenues of $70.45 million, down 16.6% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ ...